Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Ashkan Bagheri
Institution:
Shiraz University of Medical Sciences
Observed institutions:
Shiraz University,
Shiraz University of Medical Sciences
ORCID:
0000-0001-8175-301X
Observed ORCID:
0000-0001-8175-301X
OpenAlex ID:
A5046935832
Administration of COVID-19 vaccines in immunocompromised patients
2021
·
Manica Negahdaripour
, Mojtaba Shafiekhani
, et al.
·
International Immunopharmacology
·
83
PDF
Interferon-inducer antivirals: Potential candidates to combat COVID-19
2020
·
Ashkan Bagheri
, Seyed Mohammad Iman Moezzi
, et al.
·
International Immunopharmacology
·
41
PDF
Prophylactic vaccines against HPV-caused cervical cancer: novel vaccines are still demanded
2025
·
Sogand Amiri
, Shiva Rasekh
, et al.
·
Infectious Agents and Cancer
·
31
Deep survey for designing a vaccine against SARS-CoV-2 and its new mutations
2021
·
Bahareh Vakili
, Ashkan Bagheri
, et al.
·
Biologia
·
17
PDF
Designing a therapeutic and prophylactic candidate vaccine against human papillomavirus through vaccinomics approaches
2021
·
Ashkan Bagheri
, Navid Nezafat
, et al.
·
Infection Genetics and Evolution
·
14
Immunotherapeutic approaches for HPV-caused cervical cancer
2022
·
Seyed Amirreza Fatemi
, Nadia Seifi
, et al.
·
Advances in protein chemistry and structural biology
·
8
The Dual Sides of Interferon Induction in Covid-19 Treatment
2021
·
Sadra Nadimi Parashkouhi
, Pouria Mosaddeghi
, et al.
·
Trends in pharmaceutical sciences
·
3
Systems Vaccinology-Integrated Proteomics to Develop a Novel Prophylactic and Therapeutic Vaccine Against Human Papillomavirus 16
2026
·
Shirin Fathi
, Aida Solhjoo
, et al.
·
Bioinformatics and Biology Insights
Show more works
View as search
Works count:
8
Citation count:
197
H-index:
6
I10-index:
5
Year
Topic
Type